PRESCIENT NEUROPHARMA

Neurological disease therapeutic agents, namely, small molecules, proteins or conditioned media, for the treatment of neurological diseases; living cells which produce molecules to rescue and preserve nerve cells for scientific, laboratory or medical research use; bioassay system containing four phenotypes dopaminergic, GABAergic, serotonergic and cholinergic neurons, used to determine whether small molecules, proteins, and/or conditioned media from cells selectively prevent death of nerve cells

Living cells which produce molecules to rescue and preserve nerve cells for medical use; pharmaceuticals for degenerative nerve diseases

Custom manufacture of cell lines and molecules for others

Biotechnology research and development services; providing access via license agreements to cell lines for research and development by others; bioassay services, namely, services to detect specific neurotrophic factors in clinical research